Explore More at wakehealth.edu

Clinical and Translational Science Institute

Last Name

Sara Jones, Ph.D.

InstitutionWake Forest School of Medicine
DepartmentPhysiology and Pharmacology
AddressPiedmont Plaza 1
1920 W 1st St
vCardDownload vCard
    Other Positions
    InstitutionWake Forest School of Medicine
    DepartmentInstitute for Regenerative Medicine

    Collapse Research 
    Collapse research activities and funding
    F32DA005749     (JONES, SARA R)Mar 6, 1996
    Role: Principal Investigator

    R01DA014030     (JONES, SARA R)Apr 1, 2001 - Mar 31, 2016
    Animal Models of Cocaine Addiction
    Role: Principal Investigator

    U01AA014091     (JONES, SARA RAULERSON)Feb 1, 2003 - Jan 31, 2022
    Role of Kappa Opioid Receptors in Maladaptive Catecholamine Responses to Stress and Alcohol Exposure
    Role: Principal Investigator

    R21AA013900     (JONES, SARA R)Jun 1, 2004 - May 31, 2009
    Ethanol, NMDA Receptor and Dopamine Interactions
    Role: Principal Investigator

    R21DA018815     (JONES, SARA R)Sep 25, 2004 - Jul 31, 2007
    Voltammetry in Freely Moving Mice
    Role: Principal Investigator

    R01DA021325     (JONES, SARA R)Jul 20, 2007 - Jun 30, 2013
    Dopamine Transporter Changes Following Cocaine Self-Administration
    Role: Principal Investigator

    R01DA030161     (JONES, SARA R)Sep 15, 2010 - Jun 30, 2015
    Methylphenidate, Serotonin and Dopamine Interactions
    Role: Principal Investigator

    R01AA023999     (JONES, SARA RAULERSON)Aug 5, 2015 - Jun 30, 2020
    Ethanol Dependence Induced Changes in Dopamine Signaling in Basolateral Amygdala
    Role: Principal Investigator

    T32DA041349     (JONES, SARA RAULERSON)Jul 1, 2017 - Jun 30, 2022
    The Neurobiology of Drug Abuse
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Karkhanis A, Holleran KM, Jones SR. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction. Int Rev Neurobiol. 2017; 136:53-88. PMID: 29056156.
      View in: PubMed
    2. Siciliano CA, McIntosh JM, Jones SR, Ferris MJ. a6ß2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty. Neuropharmacology. 2017 Nov; 126:281-291. PMID: 28666811.
      View in: PubMed
    3. Siciliano CA, Jones SR. Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration. Neuropsychopharmacology. 2017 Aug; 42(9):1893-1904. PMID: 28139678.
      View in: PubMed
    4. Fordahl SC, Jones SR. High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling. ACS Chem Neurosci. 2017 Feb 15; 8(2):290-299. PMID: 27966885.
      View in: PubMed
    5. McGinnis MM, Siciliano CA, Jones SR. Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter. J Neurochem. 2016 09; 138(6):821-9. PMID: 27393374; PMCID: PMC5017912 [Available on 09/01/17].
    6. Rose JH, Karkhanis AN, Steiniger-Brach B, Jones SR. Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure. Int J Mol Sci. 2016 Jul 27; 17(8). PMID: 27472317; PMCID: PMC5000614.
    7. Siciliano CA, Fordahl SC, Jones SR. Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine. J Neurosci. 2016 07 27; 36(30):7807-16. PMID: 27466327; PMCID: PMC4961771 [Available on 01/27/17].
    8. Karkhanis AN, Huggins KN, Rose JH, Jones SR. Switch from excitatory to inhibitory actions of ethanol on dopamine levels after chronic exposure: Role of kappa opioid receptors. Neuropharmacology. 2016 11; 110(Pt A):190-197. PMID: 27450094.
      View in: PubMed
    9. Karkhanis AN, Beveridge TJ, Blough BE, Jones SR, Ferris MJ. The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine. Drug Alcohol Depend. 2016 09 01; 166:51-60. PMID: 27394931; PMCID: PMC5003316 [Available on 09/01/17].
    10. Siciliano CA, Locke JL, Mathews TA, Lopez MF, Becker HC, Jones SR. Dopamine synthesis in alcohol drinking-prone and -resistant mouse strains. Alcohol. 2017 Feb; 58:25-32. PMID: 27425261.
      View in: PubMed
    11. Fordahl SC, Locke JL, Jones SR. High fat diet augments amphetamine sensitization in mice: Role of feeding pattern, obesity, and dopamine terminal changes. Neuropharmacology. 2016 10; 109:170-182. PMID: 27267686; PMCID: PMC4970886 [Available on 10/01/17].
    12. Rose JH, Karkhanis AN, Chen R, Gioia D, Lopez MF, Becker HC, McCool BA, Jones SR. Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens. Int J Neuropsychopharmacol. 2016 05; 19(5). PMID: 26625893; PMCID: PMC4886667.
    13. Silverstein-Metzler MG, Shively CA, Clarkson TB, Appt SE, Carr JJ, Kritchevsky SB, Jones SR, Register TC. Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys. Psychoneuroendocrinology. 2016 06; 68:29-38. PMID: 26939086.
      View in: PubMed
    14. Siciliano CA, Calipari ES, Yorgason JT, Lovinger DM, Mateo Y, Jimenez VA, Helms CM, Grant KA, Jones SR. Increased presynaptic regulation of dopamine neurotransmission in the nucleus accumbens core following chronic ethanol self-administration in female macaques. Psychopharmacology (Berl). 2016 Apr; 233(8):1435-43. PMID: 26892380; PMCID: PMC4814331 [Available on 04/01/17].
    15. Karkhanis AN, Rose JH, Weiner JL, Jones SR. Early-Life Social Isolation Stress Increases Kappa Opioid Receptor Responsiveness and Downregulates the Dopamine System. Neuropsychopharmacology. 2016 08; 41(9):2263-74. PMID: 26860203.
      View in: PubMed
    16. Siciliano CA, Calipari ES, Yorgason JT, Mateo Y, Helms CM, Lovinger DM, Grant KA, Jones SR. Chronic ethanol self-administration in macaques shifts dopamine feedback inhibition to predominantly D2 receptors in nucleus accumbens core. Drug Alcohol Depend. 2016 Jan 01; 158:159-63. PMID: 26627912; PMCID: PMC4698076 [Available on 01/01/17].
    17. Yorgason JT, Calipari ES, Ferris MJ, Karkhanis AN, Fordahl SC, Weiner JL, Jones SR. Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum. Neuropharmacology. 2016 Feb; 101:471-9. PMID: 26525189.
      View in: PubMed
    18. Siciliano CA, Ferris MJ, Jones SR. Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine. Eur J Neurosci. 2015 Aug; 42(4):2091-6. PMID: 26037018; PMCID: PMC4540675.
    19. Melchior JR, Ferris MJ, Stuber GD, Riddle DR, Jones SR. Optogenetic versus electrical stimulation of dopamine terminals in the nucleus accumbens reveals local modulation of presynaptic release. J Neurochem. 2015 09; 134(5):833-44. PMID: 26011081; PMCID: PMC4537642.
    20. Karkhanis AN, Alexander NJ, McCool BA, Weiner JL, Jones SR. Chronic social isolation during adolescence augments catecholamine response to acute ethanol in the basolateral amygdala. Synapse. 2015 Aug; 69(8):385-95. PMID: 25963724; PMCID: PMC4578716.
    21. Siciliano CA, Calipari ES, Cuzon Carlson VC, Helms CM, Lovinger DM, Grant KA, Jones SR. Voluntary ethanol intake predicts ?-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques. J Neurosci. 2015 Apr 15; 35(15):5959-68. PMID: 25878269; PMCID: PMC4397597.
    22. Ferris MJ, Calipari ES, Rose JH, Siciliano CA, Sun H, Chen R, Jones SR. A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration. Neuropsychopharmacology. 2015 Jul; 40(8):1826-36. PMID: 25689882; PMCID: PMC4839519.
    23. Karkhanis AN, Rose JH, Huggins KN, Konstantopoulos JK, Jones SR. Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens. Drug Alcohol Depend. 2015 May 01; 150:24-30. PMID: 25765483; PMCID: PMC4387104.
    24. Richardson JR, Taylor MM, Shalat SL, Guillot TS, Caudle WM, Hossain MM, Mathews TA, Jones SR, Cory-Slechta DA, Miller GW. Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. FASEB J. 2015 May; 29(5):1960-72. PMID: 25630971; PMCID: PMC4415012.
    25. Siciliano CA, Calipari ES, Ferris MJ, Jones SR. Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration. ACS Chem Neurosci. 2015 Jan 21; 6(1):27-36. PMID: 25491345; PMCID: PMC4304501.
    26. Calipari ES, Ferris MJ, Siciliano CA, Jones SR. Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate. ACS Chem Neurosci. 2015 Jan 21; 6(1):155-62. PMID: 25474655; PMCID: PMC4304485.
    27. Karkhanis AN, Locke JL, McCool BA, Weiner JL, Jones SR. Social isolation rearing increases nucleus accumbens dopamine and norepinephrine responses to acute ethanol in adulthood. Alcohol Clin Exp Res. 2014 Nov; 38(11):2770-9. PMID: 25421514; PMCID: PMC4519347.
    28. Calipari ES, Siciliano CA, Zimmer BA, Jones SR. Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking. Neuropsychopharmacology. 2015 Feb; 40(3):728-35. PMID: 25212486; PMCID: PMC4289961.
    29. Siciliano CA, Calipari ES, Jones SR. Amphetamine potency varies with dopamine uptake rate across striatal subregions. J Neurochem. 2014 Nov; 131(3):348-55. PMID: 24988947; PMCID: PMC4205180.
    30. Ferris MJ, España RA, Locke JL, Konstantopoulos JK, Rose JH, Chen R, Jones SR. Dopamine transporters govern diurnal variation in extracellular dopamine tone. Proc Natl Acad Sci U S A. 2014 Jul 01; 111(26):E2751-9. PMID: 24979798; PMCID: PMC4084435.
    31. Ferris MJ, Milenkovic M, Liu S, Mielnik CA, Beerepoot P, John CE, España RA, Sotnikova TD, Gainetdinov RR, Borgland SL, Jones SR, Ramsey AJ. Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. Eur J Neurosci. 2014 Jul; 40(1):2255-63. PMID: 24754704; PMCID: PMC4331169.
    32. Siciliano CA, Calipari ES, Ferris MJ, Jones SR. Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci. 2014 Apr 16; 34(16):5575-82. PMID: 24741047; PMCID: PMC3988413.
    33. Calipari ES, Jones SR. Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration. Neuropharmacology. 2014 Jul; 82:1-10. PMID: 24632529; PMCID: PMC4028393.
    34. Calipari ES, Ferris MJ, Siciliano CA, Zimmer BA, Jones SR. Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter. J Pharmacol Exp Ther. 2014 May; 349(2):192-8. PMID: 24566123; PMCID: PMC3989803.
    35. Calipari ES, Sun H, Eldeeb K, Luessen DJ, Feng X, Howlett AC, Jones SR, Chen R. Amphetamine self-administration attenuates dopamine D2 autoreceptor function. Neuropsychopharmacology. 2014 Jul; 39(8):1833-42. PMID: 24513972; PMCID: PMC4059891.
    36. Rose JH, Calipari ES, Mathews TA, Jones SR. Greater ethanol-induced locomotor activation in DBA/2J versus C57BL/6J mice is not predicted by presynaptic striatal dopamine dynamics. PLoS One. 2013; 8(12):e83852. PMID: 24349553; PMCID: PMC3861521.
    37. Calipari ES, Ferris MJ, Jones SR. Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine. J Neurochem. 2014 Jan; 128(2):224-32. PMID: 24102293; PMCID: PMC3947316.
    38. Calipari ES, Beveridge TJ, Jones SR, Porrino LJ. Withdrawal from extended-access cocaine self-administration results in dysregulated functional activity and altered locomotor activity in rats. Eur J Neurosci. 2013 Dec; 38(12):3749-57. PMID: 24118121; PMCID: PMC3865236.
    39. Yorgason JT, Ferris MJ, Steffensen SC, Jones SR. Frequency-dependent effects of ethanol on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res. 2014 Feb; 38(2):438-47. PMID: 24117706; PMCID: PMC4085573.
    40. Ferris MJ, Calipari ES, Melchior JR, Roberts DC, España RA, Jones SR. Paradoxical tolerance to cocaine after initial supersensitivity in drug-use-prone animals. Eur J Neurosci. 2013 Aug; 38(4):2628-36. PMID: 23725404; PMCID: PMC3748159.
    41. Calipari ES, Ferris MJ, Zimmer BA, Roberts DC, Jones SR. Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter. Neuropsychopharmacology. 2013 Nov; 38(12):2385-92. PMID: 23719505; PMCID: PMC3799057.
    42. Ferris MJ, Calipari ES, Yorgason JT, Jones SR. Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices. ACS Chem Neurosci. 2013 May 15; 4(5):693-703. PMID: 23581570; PMCID: PMC3656744.
    43. Yorgason JT, España RA, Konstantopoulos JK, Weiner JL, Jones SR. Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats. Eur J Neurosci. 2013 Mar; 37(6):1022-31. PMID: 23294165; PMCID: PMC3746484.
    44. Calipari ES, Ferris MJ, Salahpour A, Caron MG, Jones SR. Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat Commun. 2013; 4:2720. PMID: 24193139; PMCID: PMC4017736.
    45. Espana RA, Jones SR. Presynaptic dopamine modulation by stimulant self-administration. Front Biosci (Schol Ed). 2013 Jan 01; 5:261-76. PMID: 23277050; PMCID: PMC3733372.
    46. Calipari ES, Huggins KN, Mathews TA, Jones SR. Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaques. Neurochem Int. 2012 Dec; 61(7):986-91. PMID: 22819794; PMCID: PMC3593229.
    47. Brookshire BR, Jones SR. Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine. Synapse. 2012 Sep; 66(9):844-7. PMID: 22588965; PMCID: PMC3625654.
    48. Calipari ES, Ferris MJ, Melchior JR, Bermejo K, Salahpour A, Roberts DC, Jones SR. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations. Addict Biol. 2014 Mar; 19(2):145-55. PMID: 22458761; PMCID: PMC3390453.
    49. Huggins KN, Mathews TA, Locke JL, Szeliga KT, Friedman DP, Bennett AJ, Jones SR. Effects of early life stress on drinking and serotonin system activity in rhesus macaques: 5-hydroxyindoleacetic acid in cerebrospinal fluid predicts brain tissue levels. Alcohol. 2012 Jun; 46(4):371-6. PMID: 22445804; PMCID: PMC3737489.
    50. Oleson EB, Ferris MJ, España RA, Harp J, Jones SR. Effects of the histamine H1 receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward. Eur J Pharmacol. 2012 May 15; 683(1-3):161-5. PMID: 22445882; PMCID: PMC3340496.
    51. Ferris MJ, Calipari ES, Mateo Y, Melchior JR, Roberts DC, Jones SR. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Neuropsychopharmacology. 2012 Jun; 37(7):1708-16. PMID: 22395730; PMCID: PMC3358740.
    52. Yorgason JT, Jones SR, España RA. Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection. Neuroscience. 2011 May 19; 182:125-32. PMID: 21402130; PMCID: PMC3085557.
    53. Yorgason JT, España RA, Jones SR. Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods. 2011 Nov 15; 202(2):158-64. PMID: 21392532; PMCID: PMC3149733.
    54. Ferris MJ, Mateo Y, Roberts DC, Jones SR. Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. Biol Psychiatry. 2011 Feb 01; 69(3):201-7. PMID: 20801429; PMCID: PMC3012751.
    55. España RA, Melchior JR, Roberts DC, Jones SR. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl). 2011 Mar; 214(2):415-26. PMID: 20959967; PMCID: PMC3085140.
    56. España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci. 2010 Jan; 31(2):336-48. PMID: 20039943; PMCID: PMC2881680.
    57. Oleson EB, Salek J, Bonin KD, Jones SR, Budygin EA. Real-time voltammetric detection of cocaine-induced dopamine changes in the striatum of freely moving mice. Neurosci Lett. 2009 Dec 25; 467(2):144-6. PMID: 19822192; PMCID: PMC2787452.
    58. Brookshire BR, Jones SR. Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice. Pharmacol Biochem Behav. 2009 Nov; 94(1):194-203. PMID: 19698737; PMCID: PMC2768771.
    59. España RA, Roberts DC, Jones SR. Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery. Neuroscience. 2008 Jul 31; 155(1):250-7. PMID: 18597947; PMCID: PMC2538802.
    60. Lack CM, Jones SR, Roberts DC. Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats. Psychopharmacology (Berl). 2008 Jan; 195(4):517-25. PMID: 17879088.
      View in: PubMed
    61. Budygin EA, Oleson EB, Mathews TA, Läck AK, Diaz MR, McCool BA, Jones SR. Effects of chronic alcohol exposure on dopamine uptake in rat nucleus accumbens and caudate putamen. Psychopharmacology (Berl). 2007 Sep; 193(4):495-501. PMID: 17492432.
      View in: PubMed
    62. John CE, Jones SR. Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology. 2007 Jun; 52(8):1596-605. PMID: 17459426; PMCID: PMC2041899.
    63. Mathews TA, John CE, Lapa GB, Budygin EA, Jones SR. No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics. Synapse. 2006 Sep 15; 60(4):288-94. PMID: 16786536.
      View in: PubMed
    64. Jones SR, Mathews TA, Budygin EA. Effect of moderate ethanol dose on dopamine uptake in rat nucleus accumbens in vivo. Synapse. 2006 Sep 01; 60(3):251-5. PMID: 16752364.
      View in: PubMed
    65. John CE, Jones SR. Exocytotic release of dopamine in ventral tegmental area slices from C57BL/6 and dopamine transporter knockout mice. Neurochem Int. 2006 Dec; 49(8):737-45. PMID: 16901588.
      View in: PubMed
    66. John CE, Budygin EA, Mateo Y, Jones SR. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. J Neurochem. 2006 Jan; 96(1):267-82. PMID: 16300629.
      View in: PubMed
    67. Lapa GB, Byrd GD, Lapa AA, Budygin EA, Childers SR, Jones SR, Harp JJ. The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines. Bioorg Med Chem Lett. 2005 Nov 15; 15(22):4915-8. PMID: 16165350.
      View in: PubMed
    68. Budygin EA, Mathews TA, Lapa GB, Jones SR. Local effects of acute ethanol on dopamine neurotransmission in the ventral striatum in C57BL/6 mice. Eur J Pharmacol. 2005 Oct 31; 523(1-3):40-5. PMID: 16226738.
      View in: PubMed
    69. Mateo Y, Lack CM, Morgan D, Roberts DC, Jones SR. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology. 2005 Aug; 30(8):1455-63. PMID: 15702135.
      View in: PubMed
    70. Mateo Y, Budygin EA, John CE, Banks ML, Jones SR. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens. J Neurosci Methods. 2004 Dec 30; 140(1-2):183-7. PMID: 15589348.
      View in: PubMed
    71. Lapa GB, Mathews TA, Harp J, Budygin EA, Jones SR. Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties. Eur J Pharmacol. 2005 Jan 04; 506(3):237-40. PMID: 15627433.
      View in: PubMed
    72. Mateo Y, Budygin EA, Morgan D, Roberts DC, Jones SR. Fast onset of dopamine uptake inhibition by intravenous cocaine. Eur J Neurosci. 2004 Nov; 20(10):2838-42. PMID: 15548229.
      View in: PubMed
    73. Budygin EA, Brodie MS, Sotnikova TD, Mateo Y, John CE, Cyr M, Gainetdinov RR, Jones SR. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proc Natl Acad Sci U S A. 2004 May 18; 101(20):7781-6. PMID: 15136721; PMCID: PMC419683.
    74. Mateo Y, Budygin EA, John CE, Jones SR. Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc Natl Acad Sci U S A. 2004 Jan 06; 101(1):372-7. PMID: 14691264; PMCID: PMC314192.
    75. Budygin EA, John CE, Mateo Y, Daunais JB, Friedman DP, Grant KA, Jones SR. Chronic ethanol exposure alters presynaptic dopamine function in the striatum of monkeys: a preliminary study. Synapse. 2003 Dec 01; 50(3):266-8. PMID: 14515345.
      View in: PubMed
    76. Budygin EA, John CE, Mateo Y, Jones SR. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice. J Neurosci. 2002 May 15; 22(10):RC222. PMID: 12006604.
      View in: PubMed
    Jones's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description